Clinical Impact of 16S rDNA PCR (CI16DP)

University Hospital, Strasbourg, France

Status: Unknown

Conditions: Bacterial Infections

Study type: Observational

Funder types: Other

Identifiers

NCT03915275

7407

Details and patient eligibility

About

The main objective of this study is to evaluate the impact of a positive 16S rDNA PCR in various sites on patient's management.

The secondary objectives of the protocol are:

• to evaluate bacterial identification performance
• to evaluate the effect of previous antibiotic therapy
• to analyze the management of discordant results between 16S PCR and culture identification

Enrollment: 60 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients that had a 16S rDNA PCR positive result in Strasbourg University Hospital laboratory from 2014 to 2018
• Patients consent for this analysis of their past medical history
• Legal guardians consent for the analysis of their children's medical history

Exclusion criteria

• Patients who express opposition for this study
• Incomplete clinical record